- Disclosures must never include the use of a trade name or a product-group message and must be listed once at the bottom of the poster.
- Make the title dynamic and conclusive, rather than descriptive.
- Avoid beginning sentences with numerals.
- Standard abbreviations may be used without definition. Nonstandard abbreviations should be placed in parentheses after the first use of the word or phrase abbreviated.
- No identifying information about patients participating in a study or trial should be used.
- All abbreviations must be defined before being used as an abbreviation in the text.
- All submitted abstracts must be in English
- The content of the abstract is solely the responsibility of the author. The original abstract is reprinted exactly as provided. During submission, it must clearly indicate the name of the presenting author, who will be considered the contact person for all correspondence connected with the submitted abstract.
- All submitted abstracts need to have the names and surnames of all co-authors, along with their positions in their affiliated institutions.
- The presenting author can be any of the listed authors without affiliations to industry.
- Poster submissions need to be limited to 500 words.
- An abstract must have a short, specific title (no abbreviations) that clearly indicates the nature of the investigation. It is encouraged that the title is set so as to attract the audience and to hint to the conclusion of the investigation.
- A well-written abstract typically has the following identified sections:
- Background/objectives: a brief introduction, which states the problem that you are addressing as well as some background information on the issue. The introduction of the abstract should include a very brief background 1-2 statements followed by the objectives of the investigation.
- Design and methods: the methodologies, number of test subjects and scientific approach used to conduct the research.
- Results: it is expected that authors present data that support their conclusion. Tables and graphs should include explanatory captions.
- Conclusions: further areas of research and overall conclusion of the research
- Citation: a reference list and acknowledgements, if applicable. A maximum of two tables/graphs/images can be included.
The submitting author must verify that all co-authors have read and approved the submission of the abstract.
- The same abstract and title submission indicated in this email need to be used during the congress and not another topic can fill your currently accepted slot.
- Scientific Abstract presentations will be for a maximum of 8 minutes.
- Scientific Abstract presenters need to send their powerpoint presentation 6 days prior to the congress to email@example.com with Subject: MSC2021-Presentation-OCX.X example: MSC2021-Presentation-OC2.2
- Presenting authors will be given prior instructions on the recordings and technical assistance.
- All presentations should be made available in Microsoft Office Power point.
The reviewers will judge the abstracts according to the scientiﬁc or clinical value, relevance to the conference, suitability of methods to aims, conclusions conﬁrmed by objective results, objectivity of statements, description of methods used, ethics, originality of work, standard of English and overall impression.
Upon completion of the evaluation of submitted abstracts, an ‘Accepted’ or ‘Rejected’ email will be sent to authors. Upon acceptance of an author’s submission, the following instructions below are applicable:.
- Accepted authors will receive one complimentary registration pass that will be assigned and sent up to 10 days prior to the congress
- Authors who confirm presence will receive a free communication code based on their category of submission up to 10 days before the congress.
- If you need to withdraw your abstract, a written statement listing the reasons for this decision must be sent to the abstract helpdesk at firstname.lastname@example.org no later than November 5, 2021
A disclosure form identifying commercial relationships for all co-authors must be completed by the submitting author, if their abstract has been accepted for publication. The submitting author signs and verifies disclosure on behalf of all co-authors. Disclosure information for accepted abstracts will be made available to the meeting attendees.